Toe brachial indices significantly predicted the incidence of major cardiovascular adverse events and all-cause mortality over a median follow-up of 8.39 years (p<0.001).
Cohort
Does the toe brachial index (TBI) predict major cardiovascular adverse events and all-cause mortality in patients referred to a vascular laboratory?
12,908 patients referred to a noninvasive vascular laboratory (initial cohort of 13,551 minus 643 excluded due to unobtainable TBI)
Toe brachial index (TBI) measurement
Comparison across TBI categories: normal (>0.8), borderline (0.8-0.61), mild-moderate PAD (0.6-0.21), and severe PAD (≤0.2)
Major cardiovascular adverse events (MACE: myocardial infarction, coronary revascularization, or stroke) and all-cause mortalityhard clinical
Toe brachial index is a strong predictor of long-term major cardiovascular events and all-cause mortality, offering a reliable prognostic tool when ankle-brachial indices are limited by non-compressible vessels.
Abstract Background Ankle-brachial indices (ABI) predict mortality and major cardiovascular events (MACE); however, they are unable to assess the severity of peripheral artery disease in patients with non-compressible vessels. Toe brachial indices (TBI) are less affected by non-compressibility and could be good predictors of cardiovascular morbidity and mortality. Purpose To evaluate the predictive value of TBI for MACE and all-cause mortality in a large population. Methods The initial ABIs and TBIs of all patients referred to a noninvasive vascular laboratory were obtained. We categorized patients based on the worse TBI from either leg, and each patient was classified as normal (0.8), borderline (0.8-0.61), mild-moderate PAD (0.6 - 0.21) and severe PAD (≤0.2). MACE occurring after the study were identified using ICD9/10 and procedural CPT codes and included myocardial infarction, coronary revascularization, or stroke. Survival analysis was performed using the Kaplan-Meier method with log-rank test to compare survival curves between groups. Results Of 13551 patients, we excluded 643 (5%) in whom TBI could not be obtained. Patient characteristics can be found in Table 1. There were 4,924 MACE and 3,125 deaths during the median follow up time of 8.39 years (Table1). There was a significant difference of MACE incidence (p 0.001) and mortality (p0.001) by TBI categories, and the curves separate before the 1-year mark (Figure 1A and B). Conclusion TBI is a good predictor of MACE and all-cause mortality in the short and long term and can be obtained in 95% of patients.
Building similarity graph...
Analyzing shared references across papers
Loading...
Ana I. Casanegra
D E Houghton
Fahad Shuja
European Heart Journal
Mayo Clinic
Building similarity graph...
Analyzing shared references across papers
Loading...
Casanegra et al. (Sat,) conducted a cohort in Patients referred to a noninvasive vascular laboratory (n=12,908). Toe brachial indices (TBI) vs. Normal TBI (>0.8) was evaluated on Major cardiovascular adverse events (MACE) and all-cause mortality (p=<0.001). Toe brachial indices significantly predicted the incidence of major cardiovascular adverse events and all-cause mortality over a median follow-up of 8.39 years (p<0.001).
www.synapsesocial.com/papers/698586238f7c464f2300a1c8 — DOI: https://doi.org/10.1093/eurheartj/ehaf784.3015